Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2025–2030 · research · R01
Efficient Measurement and Characterization of Genetic Interactions in Cancer Cells
Traver Hart · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · fellowship · F31
Dependence of radiosensitivity of lymphocyte subtypes on proton dose and LET and its impact on immune suppression
Madison E Grayson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R03
Administrative Supplement for Probabilistic Deep Learning Cervical Lymph-Node Auto-Segmentation For Imaging-enhanced Evaluation of Extracapsular Extension Risk (PDL-CLASIFIER)
Clifton David Fuller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Deregulation of Sulfatide Synthesis in the Development and Progression of Pancreatic Cancer Precursor Lesions
Johannes F Fahrmann · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · research · R01
Deciphering the Critical Determinants of Enteric and Tumor Niche Colonization by Microbes in Colorectal Cancer
Susan Bullman · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2027 · research · R21
A Pilot Study to Correlate 4-[18F]fluoro-1-naphthol PET/CT Imaging with Chronic Graft Versus Host Disease Manifestations
George Liwei Chen · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
Project 2: The Role of Nuclear Receptors Signaling in Bladder Cancer
Cathy Lee Mendelsohn · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U54
Core 3: Biospecimens and Pathology Core
Francisco Vega-Vazquez · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U54
Core 3: Biostatistics and Bioinformatics Core
Ryan Sun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U54
Core A: Administrative Core
Christopher R Flowers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
Pathology Core
Charles C Guo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U54
Career Enhancement Program
Christopher R Flowers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P50
Administrative Core
Richard G. Gorlick · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
Biostatistics & Bioinformatics Core
Peng Wei · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
Core C - Computational and Quantitative Imaging Core
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P50
Career Enhancement Program
Phillip Andrew Futreal · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
Project 3: InHANCE: Fibrosis Imaging Biomarkers of Radiation: An Orphan Drug Study to Evaluate REduction of SeVERity of Symptoms in a Randomized Evaluative Trial (FIBRO2SE-REVERSE)
Clifton David Fuller · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P50
Core A: Tissue and Pathology Core
Alexander Joseph Lazar · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U54
Project 1: Precision targeting of therapeutic vulnerabilities specific to African American lymphoma patients
Christopher R Flowers · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · cooperative agreement · U54
Core 1: Community Outreach and Engagement Core
Lorna H. Mcneill · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2025–2030 · program · P01
Core A - Administrative Core
Kristy Brock · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2026 · award
In vivo assessment of BET blockade combined with PARP inhibition to sensitize MPNST to radiation therapy
Keila Torres · The University of Texas MD Anderson Cancer Center · funded by Children's Tumor Foundation
2024 · award
Identification of non-canonical antigens of development of novel immunotherapies in Glioblastoma
Sachet Shukla · The University of Texas MD Anderson Cancer Center · funded by Uncle Kory Foundation
2024 · grant · Academic Research
Dissection of CAMKK2’s Tumor Cell-intrinsic and -extrinsic Roles in Prostate Cancer
Daniel Frigo · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2024 · grant · Academic Research
Dietary intervention to modulate the microbiome and immune response
Jennifer Wargo · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2024–2028 · research · R01
Angiotensin Signaling Underlies Myeloid and Sensory Disruption in Diabetes
Andrew John Shepherd · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024 · grant · Academic Research
Engineering in vivo chimeric antigen receptor (CAR) macrophages for diffuse midline glioma
Wen Jiang · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2024–2025 · award
Deciphering the role of MELK in tumor stemness and immune microenvironment in models of aggressive breast cancer
Chandra Bartholomeusz · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2024–2026 · research · R37
Dyadic yoga Program for Patients with Lung Cancer Undergoing Radiotherapy and their Family Caregivers
Kathrin Milbury · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2026 · career development · K99
The Role of Tau Phosphorylation in Diabetic Peripheral Neuropathy
James M Nichols · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2025 · research · R01
Mechanism of innate immune activation by intestinal distension
Alejandro Aballay · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2028 · award
Neoadjuvant ipilimumab/nivolumab + microbiota-directed prebiotic dietary intervention to optimize immune response in melanoma
Jennifer Leigh Mcquade · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2024 · grant · Academic Research
Immune-Related Determinants of HPV-Associated Oropharyngeal Cancer Outcomes
Guojun Li · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2024 · grant · Prevention
Expanding Access to Cervical Cancer Screening through Primary HR-HPV Testing and Self-Sampling: A Multicomponent Intervention for Safety Net Health Systems
Jane Montealegre · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2024–2029 · research · R01
Lymphedema Prevention Through Immediate Lymphatic Reconstruction
Melissa B Aldrich · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2027 · fellowship · CIHR Fellowship
Investigating the Role of MFSD14A in TGFbeta Signaling and Cancer-Induced Bone Metastasis
Haonan Zhouyao · The University of Texas MD Anderson Cancer Center · funded by Canadian Institutes of Health Research
2024–2028 · research · R01
Replication fork protection and innate immune response
Bin Wang · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024–2026 · research · R21
Bio-engineered Cell Therapy to Treat Candidiasis
Pappanaicken Rangasamy Kumar · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2024 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Xufeng Chen · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2024–2029 · research · R01
Reproductive tract organ development and differentiation
Richard R Behringer · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
